Dr. Anita Gupta, DO, MPP, PharmD
Johns Hopkins School of Medicine
Anita Gupta, M.D. is a globally recognized physician-pharmacist, World Economic Forum Member Expert, Top 10 Women of Influence-Fierce Healthcare, Harvard Business School & Princeton University alum as well as an award-winning 10KSB Goldman Sachs C-suite executive and board director. Gupta is also an inspirational, highly accomplished, health innovation and drug expert with a proven track record of advancing breakthrough initiatives. She has been recognized for breakthroughs related to the policy drug crisis as an advocate at the U.S. Food and Drug Administration to expand the use of naloxone, an overdose blocking drug, on the frontlines to address opioid overdoses and helped flag the emergence of synthetic opioids in the Philadelphia drug trade, including fentanyl.
She has been featured by New York Times, Washington Post, Forbes, CNN and MSNBC, among others on emerging crisis, biotechnology and drug matters. She is also the recipient of several awards including the Patient Advocacy Award by the National Academies, Top 100 Most Inspiring Leaders by PharmaVoice, Top 10 in Healthcare Business in Philadelphia, Top 10 Emerging Leaders by Pharmaceutical Executives, and Goldman Sachs 10K Small Business Scholars. She has also been a Sharecare Award Finalist and an Athena Pinnacle Finalist, among others.